Shanghai Model Organisms Center, Inc. (SHA:688265)
China · Delayed Price · Currency is CNY 47.32
+1.58 (3.45%)
Nov 6, 2026, 9:25 AM CST
SHA:688265 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 486.9 | 421.02 | 381.24 | 366.55 | 302.97 | 275.27 |
Revenue Growth | 16.18% | 10.44% | 4.01% | 20.99% | 10.06% | 40.31% |
Gross Profit Gross Profit Growth | 251.81 | 215.53 | 173.15 | 152.78 | 124.5 | 165.8 |
Operating Income Operating Income Growth | -6.56 | 4.45 | -23.31 | -47.04 | -43.43 | 58.17 |
Net Income Net Income Growth | 12.4 | 31.44 | 6.5 | -20.58 | -5.4 | 60.86 |
Earnings Per Share EPS Growth | 0.17 | 0.42 | 0.08 | -0.26 | -0.07 | 1.04 |
EPS Growth | -71.12% | 425.00% | - | - | - | 33.33% |
Fiscal Year | FY 2025 | FY 2024 |
|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Model Breeding Model Breeding Growth | 80.04 | 90.06 |
Standardized Model Standardized Model Growth | 203.02 | 164.77 |
Feeding Service Feeding Service Growth | 36.35 | 29.97 |
Other Model Biotechnology Services Other Model Biotechnology Services Growth | 6.69 | 6.58 |
Custom Model Custom Model Growth | 33.32 | 33.91 |
Drug Efficacy Evaluation and Phenotypic Analysis Drug Efficacy Evaluation and Phenotypic Analysis Growth | 58.87 | 53.2 |
Total Total Growth | 418.29 | 378.49 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 894.27 | 1,034 | 1,011 | 1,025 | 1,131 | 1,676 |
Total Debt Total Debt Growth | 70.05 | 56.81 | 77.42 | 94.76 | 120.95 | 26.04 |
Net Cash (Debt) Net Cash Growth | 824.22 | 976.73 | 933.68 | 930.13 | 1,010 | 1,650 |
Net Cash Growth | -12.87% | 4.61% | 0.38% | -7.89% | -38.81% | 1065.35% |
Net Cash Per Share Net Cash Per Share Growth | 11.18 | 13.05 | 11.50 | 11.75 | 13.09 | 28.20 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 49.3 | 96.92 | 71.56 | 20.08 | 18.89 | 111.46 |
Capital Expenditures CapEx Growth | -91.86 | -45.61 | -25.24 | -124.3 | -270.26 | -52.36 |
Free Cash Flow Free Cash Flow Growth | -42.56 | 51.31 | 46.33 | -104.22 | -251.37 | 59.1 |
Free Cash Flow Growth | - | 10.75% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.72% | 51.19% | 45.42% | 41.68% | 41.09% | 60.23% |
Operating Margin | -1.35% | 1.06% | -6.11% | -12.83% | -14.34% | 21.13% |
Pretax Margin | 1.94% | 6.91% | 0.72% | -8.16% | -4.86% | 25.09% |
Profit Margin | 2.55% | 7.47% | 1.70% | -5.62% | -1.78% | 22.11% |
FCF Margin | -8.74% | 12.19% | 12.15% | -28.43% | -82.97% | 21.47% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.125 | 0.125 | - | 0.130 | - | 0.257 |
Dividend Per Share Growth | 0% | - | - | - | - | - |
Dividend Yield | 0.26% | 0.30% | - | 0.34% | - | 0.37% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 281.52 | 98.65 | 269.15 | - | - | 89.74 |
Forward PE | - | 32.22 | 32.22 | 32.22 | 41.88 | - |
P/FCF Ratio | - | 60.44 | 37.74 | - | - | 92.41 |
PS Ratio | 7.51 | 7.37 | 4.59 | 8.18 | 12.61 | 19.84 |